title: Cyclosporine Neoral in renal transplant recipients: impact on hepatic dysfunction.
authors.affiliation: Urology & Nephrology Center, Mansoura University, Egypt.
authors.forename: M A
authors.initials: MA
authors.lastname: Bakr
authors.forename: A
authors.initials: A
authors.lastname: Refaie
authors.forename: M
authors.initials: M
authors.lastname: Mekresh
authors.forename: M H
authors.initials: MH
authors.lastname: Ihab
authors.forename: M
authors.initials: M
authors.lastname: Sobh
authors.forename: M A
authors.initials: MA
authors.lastname: Ghoneim
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004655:Emulsions; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008111:Liver Function Tests; D008875:Middle Aged
chemical_list: D004655:Emulsions; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin